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Abstract
Objective: To know the relationship between high-
sensitivity cardiac Troponin I (hscTnI) level with left 
ventricular dysfunction on severe preeclampsia. 
Methods: An observational analytics study with a cross-
sectional approach of ten pregnant women with severe 
preeclampsia who underwent delivery or termination 
pregnancy and then performed a transthoracic 
echocardiography examination and serum levels of hscTnI. 
Results: There is a signifi cant relationship between hscTnI 
levels and left ventricular diastolic dysfunction (p <0.05) 
Conclusions: These fi ndings of this study have signifi cant 
implications that severe preeclampsia is associated with 
heart remodelling and signifi cant change in cardiac function 
especially left ventricular dilatation and elevation of hscTnI. 
Early identifi cation and intervention may ameliorate 
subsequent cardiovascular disease so this requires regular 
and close follow-up of this target group.
Keywords: high-sensitivity cardiac Troponin I, left ventricular 
diastolic dysfunction, severe preeclampsia.
Abstrak
Tujuan: Untuk mengetahui hubungan antara kadar high-
sensitivity cardiac Troponin I (hscTnI) dengan disfungsi ven-
trikel kiri pada preeklamsia berat.
Metode: Studi observasional dengan pendekatan potong 
lintang terhadap sepuluh ibu hamil dengan preeklamsia 
berat yang menjalani persalinan atau terminasi kehamilan 
kemudian dilakukan pemeriksaan ekokardiografi  dan kadar 
hscTnI serum.
Hasil: Ada hubungan yang bermakna antara kadar hscTnI 
dengan disfungsi diastolik ventrikel kiri (p <0,05).
Kesimpulan: Temuan penelitian awal ini memiliki implikasi 
yang signifi kan bahwa preeklamsia berat berhubungan 
dengan remodeling jantung dan perubahan signifi kan pada 
fungsi jantung terutama dilatasi ventrikel kiri disertai pen-
ingkatan kadar hscTnI. Identifi kasi dan intervensi dini dapat 
memperbaiki perjalanan penyakit kardiovaskular sehingga 
diperlukan pengawasan lanjut pada kelompok pasien ini.
Kata kunci: disfungsi diastolik ventrikel, high-sensitivity 
cardiac troponin I jantung sensitivitas tinggi, kiri, preeklamsia 
berat
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INTRODUCTION
Preeclampsia is one of the leading causes 
of maternal and fetal death in developing 
countries. The pathogenesis of preeclampsia is 
not fully understood. The main causative factor 
is thought to be poor uteroplacental circulation 
caused by inadequate remodelling of the 
spiral arteries at between 8 and 18 weeks of 
gestation.1The result of this poor placentation 
process is placental hypoperfusion and oxidative 
stress. Maternal signs and symptoms result 
from concomitant endothelial dysfunction 
and vascular infl ammation. Endothelial cells 
in the uteroplacental circulation that undergo 
hypoperfusion will release free radicals and fat 
peroxides.1,2
Cardiovascular function and hemodynamics 
undergo signifi cant changes during pregnancy, 
especially at delivery until one week postpartum 
there is a maximal cardiac change in morphology. 
The main change that occurs during pregnancy 
is an increase in cardiac output. These changes 
are associated with an increase in heart rate and 
blood volume, as well as a decrease in systemic 
vascular resistance during pregnancy. Conversely, 
preeclampsia is associated with decreased 
intravascular volume and increased arteriolar 
vasospasm leading to decreased cardiac output 
and increased systemic vascular resistance. In 
preeclampsia, there will be an excessive activity 
of the sympathetic system so that it will decrease 
blood reserves in the splanchnic organs causing 
increased venous return. This increase increases 
inferior vena cava diameter and left atrial volume 
so that patients with preeclampsia increase the 
risk of developing heart failure.3-5 Decreased 
stroke volume, diastolic dysfunction, and left 
ventricular remodelling were most common 
in severe preeclampsia.6 Research on the 
complications of preeclampsia in the incidence 
of heart failure has been investigated by several 
centres in Indonesia. Fifteen per cent of pregnant 
patients with heart failure at Kariadi General 
Hospital Semarang is caused by preeclampsia.7
Determining the presence of damage to the 
heart is an important factor for the evaluation of a 
patient with preeclampsia and plays an important 
role in the management and determination of 
the patient's prognosis. Cardiac biomarkers can 
be used for early identifi cation of potential heart 
problems, one of which is troponin. The Troponin 
complex plays an important role in the regulation 
of the contraction of the skeletal and cardiac 
muscles. The complex consists of 3 subunits, 
namely Troponin T, Troponin I and Troponin 
C. Troponin I and T are both typical for the 
heart, however cardiac Troponin I is expressed 
exclusively in the heart muscle in contrast to 
cardiac Troponin T which may still be expressed 
by diseased skeletal muscle. Cardiac Troponin I 
refl ect cardiac remodelling and can be used as a 
predictor of patients with heart failure. The level 
increases in response to myocardial damage and 
is one of the most specifi c and sensitive markers of 
ischemic or non-ischemic myocardial damage.8-10 
However, several other studies suggest that there 
is no association between increased cardiac 
Troponin I and preeclampsia.11-13
Recent advances in testing technology have 
resulted in increased sensitivity, now being able 
to calculate troponin levels with a high degree 
of precision at very low plasma concentrations. 
High sensitivity cardiac Troponin I (hscTnI) 
can detect troponin in more than 50% of the 
reference normal population and can identify 
patients above or below the 99th percentile 
with optimal accuracy.10,14 This study aimed to 
assess the relationship between hscTnI levels 
and left ventricular diastolic dysfunction in 
patients with severe preeclampsia obtained from 
echocardiographic examinations.
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This research was conducted in the Department 
of Maternal-Fetal Medicine and Department of 
Cardiology Vascular Medicine, Dr. Kariadi General 
Hospital, Semarang. The inclusion criteria were 
patients with severe preeclampsia according to 
the 2016 PNPK Preeclampsia criteria with single 
pregnancy and delivery/termination at this 
hospital. The exclusion was made if there was a 
history of Diabetes mellitus, chronic hypertension, 
previous heart disease (congenital, acquired, 
cardiomyopathy and arrhythmias), chronic 
kidney disease, and receiving inotropic drugs 
and methylergometrine maleate. Study subjects 
were selected using consecutive sampling.
Observational analytic, Cross-sectional 
research was done in severe preeclampsia 
women who underwent echocardiography to 
assess the left ventricular diastolic dysfunction 
and measured hscTnI levels. Ten pregnant 
women were included in this study. The study 
was approved by the Ethical Committee of the 
Medical Faculty of Universitas Diponegoro and 
Dr. Kariadi General Hospital.
Patients with severe preeclampsia who met 
the inclusion and exclusion criteria were tested 
for transthoracic echocardiography (TTE), 
including 2-dimensional images, M-mode, color 
doppler, and tissue doppler by Cardiologists who 
served in the echocardiography diagnostic room. 
Echocardiography is performed a maximum of 
48 hours after delivery. Echocardiography results 
obtained were then determined the presence of 
diastolic dysfunction according to the guidelines 
and recommendations of the American Society 
of Echocardiography.15 Blood samples were 
taken on the same day the patient was examined 
for echocardiography and then frozen and sent 
to the laboratory, serum hscTnI was measured by 
the ARCHITECT STAT (Abbott) immunoassay kit, 
then analyzed for the presence of left ventricular 
dysfunction.
SPSS software was used for statistical analysis. 
A comparison between groups was analyzed 
with an independent t-test. Data with abnormal 
distribution were analyzed using the Mann-
Based on table 1, age, gestational age, systolic 
and diastolic blood pressure, body mass index 
(BMI), glomerular fi ltration rate, mode of delivery, 
parity, and birth weight were not associated with 
left ventricular diastolic dysfunction (p> 0.05).
Whitney U test. Non-parametric data were 
analyzed using Fisher’s Exact test. A value of p < 
0.05 was considered signifi cant.
RESULTS
At the end of the study, 10 subjects with severe 
preeclampsia were obtained and valid for analysis. 
The mean age was 30±6 years and advanced 
maternal age (≥35 years) was observed in 30%. 
Fifty per cent of cases occur when gestational 
age is less than 34 weeks (early-onset severe 
preeclampsia). Cesarean section accounted for 
60% of deliveries. The average weight of a baby 
born was 2107±559 grams. 
Table 1. Bivariate Test for the Relationship between Several Factors and Left Ventricular Diastolic function
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Early-onset (< 34 )
Late-onset (≥ 34 )
Systolic blood pressure (mmHg)
Diastolic blood pressure (mmHg)
Body mass index (kg/m2)
< 30
≥ 30 











¥: Independent t-test, *:  Mann-Whitney U test,  Ʃ: Fisher’s Exact test, signifi cant if p < 0.05
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The Shapiro-Wilk normality test was used to 
determine the distribution of hscTnI level data. 
From the normality test, the data distribution of 
hscTnI levels was normal so that the Independent 
T-Test was carried out between the hscTnI level 
and left ventricular diastolic dysfunction and 
obtained p = 0.047 (p<0.05). Based on the above 
results, there is a signifi cant relationship between 
hscTnI levels and left ventricular diastolic 
dysfunction.
DISCUSSION
Our study was conducted to determine the 
relationship between hscTnI levels and left 
ventricular diastolic dysfunction in patients 
with severe preeclampsia. Increased cardiac 
troponin I level in preeclampsia, as examined 
in this study, suggests the possibility that 
preeclampsia may have a deleterious effect on 
heart cells in pregnant women with preeclamptic 
conditions. Preeclampsia is associated with 
impaired vascular reactivity, hemodynamic 
index, and left ventricular function. Thus, left 
ventricular remodelling abnormalities as seen 
in some patients with preeclampsia can lead 
to left ventricular hypertrophy. Left ventricular 
involvement in preeclampsia is thought to cause 
cardiac ischemia, which can result in changes in 
several biomarkers of heart function.16 This study 
is consistent with the study of Morton et al. which 
measured hscTnI levels in 40 asymptomatic 
preeclamptic women results showed that 
hscTnI levels increased by 25% of the sample. 
Echocardiographic studies that were also carried 
out showed the presence of diastolic dysfunction 
in about 20% of women with preeclampsia.14 This 
is also following the study who compared hscTnI 
levels in normal pregnancy and preeclampsia 
and its relationship with impaired left ventricular 
function at the cellular level.10
Serum cardiac troponin is a specifi c and 
sensitive biomarker of cardiac injury that can 
detect even minor cardiac injury. Elevated cardiac 
troponin I after delivery could indicate myocardial 
injury during the delivery, signifi cant rise in the 
early postpartum period. Preeclampsia induces 
the release of antiangiogenic factors, which impair 
vascular endothelial function in the placental 
and maternal circulation. These changes could 
lead to myocardial injury due to microcirculatory 
disorders in addition to hypertension’s effects.3 
Transient damage of this myocyte with or without 
pathological cardiac remodelling occurred even 
in normal pregnant women postpartum because 
of cardiovascular maladaptation to the volume-
overloaded state at term.17
Limitations of this study included small study 
size, absence of control group of normotensive 
pregnancy, and the measurement of hscTnI 
on only one occasion. HscTnI assays also 
more prone than sensitive assays to analytical 
problems because small differences can be of 
such importance.14
CONCLUSION
These fi ndings of this study have signifi cant 
implications that severe preeclampsia is associated 
with heart remodelling and signifi cant change 
in cardiac function especially left ventricular 
dilatation and elevation of cardiovascular 
biomarkers (hscTnI). Early identifi cation and 
intervention may ameliorate subsequent 
cardiovascular disease so this requires regular 
and close follow-up of this target group.
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